ConductScience.org, home

Paper41847148

Nanotechnology-based targeted delivery strategies for the treatment of Alzheimer's disease.

Yuan X and 2 others. Nanoscale Adv, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Nanotechnology-based targeted delivery strategies for the treatment of Alzheimer's disease. Papers, record 41847148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41847148

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanotechnology-based targeted delivery strategies for the treatment of Alzheimer's disease.
PubMed
Journal
Nanoscale Adv
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yuan XXiaokui
2Tang QQin
3Wang TTonghttps://orcid.org/0009-0002-4467-785X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References156

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134046943Traceable Nano-Biohybrid Complexes by One-Step Synthesis as CRISPR-Chem Vectors for Neurodegenerative Diseases Synergistic Treatment.Adv Mater2021https://conductscience.org/library/papers/34046943PubMed
228734741
Beneficial effects of TQRF and TQ nano- and conventional emulsions on memory deficit, lipid peroxidation, total antioxidant status, antioxidants genes expression and soluble Aβ levels in high fat-cholesterol diet-induced rats.
Chem Biol Interact2017https://conductscience.org/library/papers/28734741PubMed
331775806Autophagy protein NRBF2 has reduced expression in Alzheimer's brains and modulates memory and amyloid-beta homeostasis in mice.Mol Neurodegener2019https://conductscience.org/library/papers/31775806PubMed
437183523The amyloid cascade hypothesis: an updated critical review.Brain2023https://conductscience.org/library/papers/37183523PubMed
535897815Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment.Int J Mol Sci2022https://conductscience.org/library/papers/35897815PubMed
635456590Intranasal Cerium Oxide Nanoparticles Ameliorate Cognitive Function in Rats with Alzheimer's via Anti-Oxidative Pathway.Pharmaceutics2022https://conductscience.org/library/papers/35456590PubMed
728698078Chitosan nanofilm and electrospun nanofiber for quick drug release in the treatment of Alzheimer's disease: In vitro and in vivo evaluation.Int J Biol Macromol2017https://conductscience.org/library/papers/28698078PubMed
837075744Study on the Role of an Erythrocyte Membrane-Coated Nanotheranostic System in Targeted Immune Regulation of Alzheimer's Disease.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37075744PubMed
936632961Novel naringin tablet formulations of agro-resides based nano/micro crystalline cellulose with neuroprotective and Alzheimer ameliorative potentials.Int J Biol Macromol2023https://conductscience.org/library/papers/36632961PubMed
1030603085Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis.Transl Neurodegener2018https://conductscience.org/library/papers/30603085PubMed
1139389804Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration.Trends Neurosci2024https://conductscience.org/library/papers/39389804PubMed
1230504054A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.J Photochem Photobiol B2019https://conductscience.org/library/papers/30504054PubMed
1335839463Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer's Disease.ACS Nano2022https://conductscience.org/library/papers/35839463PubMed
1426440073GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.ACS Nano2015https://conductscience.org/library/papers/26440073PubMed
1515322526Strategies for disease modification in Alzheimer's disease.Nat Rev Neurosci2004https://conductscience.org/library/papers/15322526PubMed
1637947289Macrophage Membrane-Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi-Targeting of Alzheimer's Disease.Adv Healthc Mater2024https://conductscience.org/library/papers/37947289PubMed
1733793837Anti-Aβ-scFv-loaded polymeric nano-micelles with enhanced plasma stability.J Pharm Pharmacol2021https://conductscience.org/library/papers/33793837PubMed
1834727550The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer's Disease Rat Model.Neuropsychobiology2022https://conductscience.org/library/papers/34727550PubMed
1935278428Box-Behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting.Chem Phys Lipids2022https://conductscience.org/library/papers/35278428PubMed
2030691325Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer's disease.J Drug Target2019https://conductscience.org/library/papers/30691325PubMed

See all 156 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42980730From molecular pathways to nanocarrier design: a translational framework for lipid-based nanoparticles in Alzheimer's disease.Discov Nano2026https://conductscience.org/library/papers/42980730PubMed
42764330Targeting the BACE1-GSK-3β Signaling Axis in Alzheimer's Disease: From Molecular Crosstalk to Nanotechnology-Based Translational Strategies.Mol Neurobiol2026https://conductscience.org/library/papers/42764330PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41847148

GET https://conductscience.org/api/papers/v1/41847148/references?page=2